RHYTHM PHARMACEUTICALS, INC. (RYTM) Retained Earnings (Accumulated Deficit) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Rhythm Pharmaceuticals, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2016 to 2024.
  • Rhythm Pharmaceuticals, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.04 B, a 35.9% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.04 B -$274 M -35.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$895 M -$185 M -26% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$853 M -$186 M -27.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$809 M -$182 M -29.1% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 -$762 M -$181 M -31% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 -$710 M -$181 M -34.2% Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$668 M -$181 M -37.3% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$627 M -$176 M -39% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 -$582 M -$166 M -40% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 -$529 M -$69.6 M -15.2% Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$486 M -$61.6 M -14.5% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 -$451 M -$60.4 M -15.5% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 -$416 M -$56.1 M -15.6% Mar 31, 2021 10-Q 2021-05-03
Q4 2020 -$459 M -$134 M -41.2% Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$424 M -$132 M -45.2% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 -$391 M -$134 M -52.4% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 -$359 M -$146 M -68.3% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 -$325 M -$141 M -76.2% Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$292 M -$133 M -83.8% Sep 30, 2019 10-Q 2019-11-01
Q2 2019 -$256 M -$115 M -81.7% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 -$214 M -$86.9 M -68.6% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 -$185 M -$74.4 M -67.4% Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$159 M -$59.4 M -59.5% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 -$141 M Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$127 M Mar 31, 2018 10-Q 2018-05-14
Q4 2017 -$110 M -$33.7 M -44% Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$99.7 M Sep 30, 2017 10-Q 2017-11-14
Q4 2016 -$76.5 M Dec 31, 2016 8-K 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.